Institute of Cancer Research

Institute of Cancer Research. The Institute of Cancer Research (ICR) is a Cancer Research UK-funded research institute located in London, United Kingdom, and a charity with a royal charter. It was founded in 1909 and has been responsible for several significant developments in cancer research, including the discovery of tamoxifen by Professor Alexander Haddow and the development of carboplatin by Professor Kenneth Harrap. The ICR has collaborated with numerous organizations, including University of London, Imperial College London, and the National Health Service.

● History

The Institute of Cancer Research was founded in 1909 by The Royal Marsden Hospital with the support of King Edward VII. The ICR's early work focused on the study of radiation therapy and its effects on cancer cells, with researchers such as Marie Curie and Ernest Rutherford contributing to the field. In the 1920s, the ICR began to explore the use of chemotherapy in cancer treatment, with Professor Edward Mellanby and Professor Alexander Haddow leading the research efforts. The ICR has also worked closely with other institutions, including the University of Cambridge, University of Oxford, and the Francis Crick Institute, to advance cancer research.

● Research

The Institute of Cancer Research conducts research in various areas, including oncology, genomics, and epigenetics. Researchers at the ICR have made significant contributions to the understanding of cancer biology, including the discovery of BRCA1 and BRCA2 genes by Professor Alan Ashworth and the development of PARP inhibitors by Professor Chris Lord. The ICR has also collaborated with pharmaceutical companies such as AstraZeneca, GlaxoSmithKline, and Pfizer to develop new cancer treatments. Additionally, the ICR has worked with research institutions such as the Sanger Institute, Wellcome Trust, and the European Molecular Biology Laboratory to advance cancer research.

● Organisation

The Institute of Cancer Research is a charity and a company limited by guarantee, with a board of trustees that includes Professor Paul Workman and Dame Julia Higgins. The ICR is also a partner of the National Institute for Health Research and has close ties with NHS Foundation Trusts such as the Royal Marsden NHS Foundation Trust. The ICR has a strong relationship with universities such as University College London, King's College London, and Queen Mary University of London, and has collaborated with research councils such as the Medical Research Council and the Biotechnology and Biological Sciences Research Council.

● Facilities

The Institute of Cancer Research has two main sites, one in Chelsea and one in Sutton, with state-of-the-art facilities for cancer research. The ICR's facilities include laboratories, clinics, and imaging facilities, and are equipped with the latest technology, including next-generation sequencing and mass spectrometry. The ICR has also invested in high-performance computing facilities, including a supercomputer provided by IBM, to support data analysis and bioinformatics research. The ICR's facilities are also used by collaborating institutions such as the University of Manchester and the University of Edinburgh.

● Notable_Affiliations_and_Partnerhips

The Institute of Cancer Research has numerous affiliations and partnerships with other organizations, including Cancer Research UK, The Royal Marsden Hospital, and the National Health Service. The ICR is also a member of the Association of Medical Research Charities and the European Association for Cancer Research. The ICR has collaborated with international organizations such as the World Health Organization, the National Cancer Institute, and the American Cancer Society to advance cancer research globally. Additionally, the ICR has partnerships with industry leaders such as Roche, Merck, and Bristol-Myers Squibb to develop new cancer treatments.

● Awards_and_Recognition

The Institute of Cancer Research has received numerous awards and recognition for its contributions to cancer research, including the Queen's Anniversary Prize and the Times Higher Education Award for Outstanding Contribution to Innovation and Technology. The ICR's researchers have also received individual awards, such as the Royal Medal and the Knighthood, for their contributions to cancer research. The ICR has been ranked as one of the top cancer research centers in the world by QS World University Rankings and has been recognized as a centre of excellence by the European Commission. The ICR's work has also been recognized by celebrities such as Stephen Fry and Kylie Minogue, who have supported the ICR's fundraising efforts. Category:Institutes of Cancer Research